Form 4 Tracker
Richard R. Deluca

EVP&Pres, Merck Animal Heallth · 6 filings · Latest: Aug 10, 2026

Merck & Co., Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
MRK
RICHARD ROBERT DELUCA JRAug 12, 2026
Proposed Sale
$131.6311,699$1.5M
MRK
Richard R. DelucaEVP&Pres, Merck Animal HeallthAug 12, 2026
Sale
$131.6311,699$1.5M110,167.07
MRK
Richard R. DelucaEVP&Pres, Merck Animal HeallthAug 11, 2026
Sale
$131.7612,837$1.7M121,866.07
MRK
Richard R. DelucaEVP&Pres, Merck Animal HeallthAug 10, 2026
Sale
$130.4320,784$2.7M134,703.07
MRK
RICHARD ROBERT DELUCA JRAug 11, 2026
Proposed Sale
$131.7612,837$1.7M
MRK
RICHARD ROBERT DELUCA JRAug 10, 2026
Proposed Sale
$130.4320,784$2.7M
MRK
Richard R. DelucaEVP&Pres, Merck Animal HeallthAug 6, 2026
Sale
$130.386,050$788.8K155,487.07
MRK
RICHARD ROBERT DELUCA JRAug 6, 2026
Proposed Sale
$130.386,050$788.8K
MRK
Richard R. DelucaEVP&Pres, Merck Animal HeallthApr 29, 2026
Option Exercise
$110.032,518$277.1K162,778.07
MRK
RICHARD ROBERT DELUCA JR.Feb 6, 2026
Proposed Sale
$120.9237,685$4.6M
MRK
Richard R. DelucaEVP&Pres, Merck Animal HeallthFeb 6, 2026
Sale
$120.9237,685$4.6M160,173.834